KKR enters the first week of September with an interesting disconnect: the street is lifting price targets aggressively, yet the stock has slipped nearly 1% on the week to $107.73, sitting roughly 16% below the consensus mean target of $128.
The most striking development from the Street this week came from Oppenheimer, where analyst Chris Kotowski raised his price target to $166 from $139 on August 27, while maintaining an Outperform rating. That target sits well above consensus and represents a 54% premium to Friday's close. The broader analyst community has been moving in the same direction — four separate firms lifted targets after KKR's last earnings print in late July, including RBC Capital to $134, Barclays to $135, BMO Capital to $118, and Argus Research to $125. The one exception is Morgan Stanley, which trimmed its target modestly to $147 from $153 in July while holding Overweight. Overall, the analyst skew is decisively constructive, but there's a clear divergence between where buy-side conviction is priced and where the stock is actually trading. TD Cowen's Hold at $111 is the lone cautious voice in the recent flow, and even that target is only marginally above the current price.
The bull case rests on KKR's standing as a global alternative asset management franchise — diversified across private equity, real assets, and credit, with an ambitious path toward $1 trillion in AUM by 2029. Forward earnings momentum is genuinely strong: the EPS 12-month forward year-on-year growth factor ranks in the 63rd percentile, and the 30-day EPS momentum score is a notably high 75. The bear case, as Benzinga's current framing captures it, is about execution risk — the $7 ANI per share target by 2026 leaves limited room for error, and macro volatility combined with delayed portfolio company exits could erode realized carry. The PE multiple has expanded roughly 1 point over 30 days to around 15.6x, a modest re-rating but not one that looks stretched given the growth profile. The dividend score factor ranks in the 96th percentile, though the most recent dividend data in the system dates to 2022, so that rank likely reflects the yield rather than recent dividend growth.
Positioning data tells a calm story rather than a charged one. Short interest is low at 1.4% of the free float — well within the range where it is not a primary driver of price action. That said, it has risen approximately 7% over the past week, reversing a decline from earlier in August when shorts pulled back from a peak of roughly 1.87% in mid-August. The borrow market is extremely relaxed: availability is effectively uncapped, with over 420 million shares available to lend and a cost to borrow of just 0.31%, down sharply over 30 days from higher levels in July. There is no meaningful short squeeze dynamic here. The ORTEX short score is a modest 31.7, barely changed over the past week and well below levels that would suggest elevated short pressure.
Options sentiment is structurally defensive but not unusually so. The put/call ratio is running at 1.91, close to its 20-day average of 1.88 and only half a standard deviation above it. That elevated structural PCR — the 52-week low is 0.98 — reflects the general hedging posture typical of a large-cap alternatives manager trading at a meaningful discount to analyst targets, not any acute fear of downside. The pattern is consistent across recent weeks and reads as steady rather than alarming.
The peer group reinforces the soft tape. BX fell 4.4% on the week and CG dropped 4.3%, both underperforming KKR's modest decline. ARES held up better at -1.7%, and STEP bucked the group with a 1.2% gain. The relative resilience in KKR and Ares suggests investors are differentiating within the sector, favouring more diversified or credit-heavy business models over pure-play buyout names in the current rate environment.
The next catalyst is KKR's Q3 earnings print, slated for October 30. The two most recent results produced next-day moves of -0.9% and +2.2% respectively, both followed by 4%-plus gains over the subsequent five trading days — a pattern worth tracking as the market digests the gap between current price and analyst targets between now and then.
See the live data behind this article on ORTEX.
Open KKR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
